L., Hart, L., Alkhouri, R., et al
A phase II open label study of neihulizumab, an anti-Cd162 (Psgl-1) antibody, in patients with moderate to severe active, anti-Tnf And/or anti-integrin refractory ulcerative colitis
Contents What Are Semaglutide and Tirzepatide, and Why Are They Used in Aesthetics
Manufacturer Teva announced it would start selling an authorized generic of Victoza (liraglutide), its popular type 2 diabetes drug
The North American GLP-1 Agonists Market Holds A Significant Revenue Share In The Region
Patients experiencing persistent sleep problems should not assume a direct causal relationship with tirzepatide without thorough clinical assessment